These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

685 related items for PubMed ID: 26365159

  • 1. Comprehensive urinary metabolomic profiling and identification of potential noninvasive marker for idiopathic Parkinson's disease.
    Luan H, Liu LF, Tang Z, Zhang M, Chua KK, Song JX, Mok VC, Li M, Cai Z.
    Sci Rep; 2015 Sep 14; 5():13888. PubMed ID: 26365159
    [Abstract] [Full Text] [Related]

  • 2. LC-MS-based urinary metabolite signatures in idiopathic Parkinson's disease.
    Luan H, Liu LF, Meng N, Tang Z, Chua KK, Chen LL, Song JX, Mok VC, Xie LX, Li M, Cai Z.
    J Proteome Res; 2015 Jan 02; 14(1):467-78. PubMed ID: 25271123
    [Abstract] [Full Text] [Related]

  • 3. Comprehensive metabolic profiling of Parkinson's disease by liquid chromatography-mass spectrometry.
    Shao Y, Li T, Liu Z, Wang X, Xu X, Li S, Xu G, Le W.
    Mol Neurodegener; 2021 Jan 23; 16(1):4. PubMed ID: 33485385
    [Abstract] [Full Text] [Related]

  • 4. Identification of novel biomarkers for Parkinson's disease by metabolomic technologies.
    Hatano T, Saiki S, Okuzumi A, Mohney RP, Hattori N.
    J Neurol Neurosurg Psychiatry; 2016 Mar 23; 87(3):295-301. PubMed ID: 25795009
    [Abstract] [Full Text] [Related]

  • 5. Potential biomarkers of Parkinson's disease revealed by plasma metabolic profiling.
    Zhao H, Wang C, Zhao N, Li W, Yang Z, Liu X, Le W, Zhang X.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Apr 01; 1081-1082():101-108. PubMed ID: 29518718
    [Abstract] [Full Text] [Related]

  • 6. Metabolomic Analysis Using Liquid Chromatography/Mass Spectrometry for Gastric Cancer.
    Liang Q, Wang C, Li B.
    Appl Biochem Biotechnol; 2015 Aug 01; 176(8):2170-84. PubMed ID: 26088916
    [Abstract] [Full Text] [Related]

  • 7. Urinary and Plasma Metabolomics Identify the Distinct Metabolic Profile of Disease State in Chronic Mouse Model of Multiple Sclerosis.
    Singh J, Cerghet M, Poisson LM, Datta I, Labuzek K, Suhail H, Rattan R, Giri S.
    J Neuroimmune Pharmacol; 2019 Jun 01; 14(2):241-250. PubMed ID: 30315511
    [Abstract] [Full Text] [Related]

  • 8. A metabolomic signature of treated and drug-naïve patients with Parkinson's disease: a pilot study.
    Troisi J, Landolfi A, Vitale C, Longo K, Cozzolino A, Squillante M, Savanelli MC, Barone P, Amboni M.
    Metabolomics; 2019 Jun 10; 15(6):90. PubMed ID: 31183578
    [Abstract] [Full Text] [Related]

  • 9. Urinary metabolic phenotyping of mucopolysaccharidosis type I combining untargeted and targeted strategies with data modeling.
    Tebani A, Schmitz-Afonso I, Abily-Donval L, Héron B, Piraud M, Ausseil J, Brassier A, De Lonlay P, Zerimech F, Vaz FM, Gonzalez BJ, Marret S, Afonso C, Bekri S.
    Clin Chim Acta; 2017 Dec 10; 475():7-14. PubMed ID: 28982054
    [Abstract] [Full Text] [Related]

  • 10. Identification of potential urine biomarkers in idiopathic parkinson's disease using NMR.
    Kumari S, Kumaran SS, Goyal V, Sharma RK, Sinha N, Dwivedi SN, Srivastava AK, Jagannathan NR.
    Clin Chim Acta; 2020 Nov 10; 510():442-449. PubMed ID: 32791135
    [Abstract] [Full Text] [Related]

  • 11. Exploratory investigation of plasma metabolomics in human lung adenocarcinoma.
    Wen T, Gao L, Wen Z, Wu C, Tan CS, Toh WZ, Ong CN.
    Mol Biosyst; 2013 Sep 10; 9(9):2370-8. PubMed ID: 23857124
    [Abstract] [Full Text] [Related]

  • 12. Discovery of common urinary biomarkers for hepatotoxicity induced by carbon tetrachloride, acetaminophen and methotrexate by mass spectrometry-based metabolomics.
    Kumar BS, Chung BC, Kwon OS, Jung BH.
    J Appl Toxicol; 2012 Jul 10; 32(7):505-20. PubMed ID: 22131085
    [Abstract] [Full Text] [Related]

  • 13. Urinary Metabolomic Profiling in Chronic Hepatitis B Viral Infection Using Gas Chromatography/Mass Spectrometry.
    Dittharot K, Jittorntam P, Wilairat P, Sobhonslidsuk A.
    Asian Pac J Cancer Prev; 2018 Mar 27; 19(3):741-748. PubMed ID: 29582629
    [Abstract] [Full Text] [Related]

  • 14. Metabolic profiling of potential lung cancer biomarkers using bronchoalveolar lavage fluid and the integrated direct infusion/ gas chromatography mass spectrometry platform.
    Callejón-Leblic B, García-Barrera T, Grávalos-Guzmán J, Pereira-Vega A, Gómez-Ariza JL.
    J Proteomics; 2016 Aug 11; 145():197-206. PubMed ID: 27255828
    [Abstract] [Full Text] [Related]

  • 15. Urine metabolic fingerprinting using LC-MS and GC-MS reveals metabolite changes in prostate cancer: A pilot study.
    Struck-Lewicka W, Kordalewska M, Bujak R, Yumba Mpanga A, Markuszewski M, Jacyna J, Matuszewski M, Kaliszan R, Markuszewski MJ.
    J Pharm Biomed Anal; 2015 Aug 11; 111():351-61. PubMed ID: 25684700
    [Abstract] [Full Text] [Related]

  • 16. Urinary Metabolomic Profiling to Identify Potential Biomarkers for the Diagnosis of Behcet's Disease by Gas Chromatography/Time-of-Flight-Mass Spectrometry.
    Ahn JK, Kim J, Hwang J, Song J, Kim KH, Cha HS.
    Int J Mol Sci; 2017 Nov 02; 18(11):. PubMed ID: 29099052
    [Abstract] [Full Text] [Related]

  • 17. Metabolic signatures of esophageal cancer: NMR-based metabolomics and UHPLC-based focused metabolomics of blood serum.
    Zhang X, Xu L, Shen J, Cao B, Cheng T, Zhao T, Liu X, Zhang H.
    Biochim Biophys Acta; 2013 Aug 02; 1832(8):1207-16. PubMed ID: 23524237
    [Abstract] [Full Text] [Related]

  • 18. Urinary metabolomic study of systemic lupus erythematosus based on gas chromatography/mass spectrometry.
    Yan B, Huang J, Dong F, Yang L, Huang C, Gao M, Shi A, Zha W, Shi L, Hu X.
    Biomed Chromatogr; 2016 Nov 02; 30(11):1877-1881. PubMed ID: 27061577
    [Abstract] [Full Text] [Related]

  • 19. Metabolomic biomarkers as strong correlates of Parkinson disease progression.
    LeWitt PA, Li J, Lu M, Guo L, Auinger P, Parkinson Study Group–DATATOP Investigators.
    Neurology; 2017 Feb 28; 88(9):862-869. PubMed ID: 28179471
    [Abstract] [Full Text] [Related]

  • 20. [Urinary metabolomics study of renal cell carcinoma based on gas chromatography-mass spectrometry].
    Zhang L, Li L, Kong H, Zeng F.
    Nan Fang Yi Ke Da Xue Xue Bao; 2015 May 28; 35(5):763-6. PubMed ID: 26018279
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.